TipRanks
Go Ultimate55% OFF

DEFJ, LLC Insider Profile

4 Followers

DEFJ, LLC, Ten Percent Owner at TransCode Therapeutics, holds 14.13M shares in TransCode Therapeutics (Ticker: RNAZ).

DEFJ, LLC's Trading History

RNAZ
TransCode Therapeutics
Aug 05, 2026Ten Percent OwnerUninformative Buy―$23.04M
RNAZ
Insider Shares: 14.13M (1335.36%)

DEFJ, LLC has not reported any informative transactions for RNAZ, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 05, 2026Uninformative Buy$0.0013,834,441$0.00―

You May Also Like

DEFJ, LLC insider profile FAQ

What stocks does DEFJ, LLC hold?
DEFJ, LLC holds: RNAZ stocks.
What is DEFJ, LLC's role in TransCode Therapeutics?
DEFJ, LLC's role in TransCode Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.